COVID iStock-1215229116.jpg
DR. WAGSHUL AND FRONT LINE COVID-19 CRITICAL CARE ALLIANCE  (FLCCC) BUILD MOMENTUM TOWARD HELPING COVID PATIENTS

In March 2020, a group of colleagues with over 200 years of combined experience in Critical Care and Emergency Medicine, as well as long-standing shared interests in developing effective treatments for critical illnesses formed the FLCCC Alliance.

 

Dr. Fred A. Wagshul, M.D., Medical Director at Lung Center of America, is part of the FLCCC Alliance. Doctor Wagshul along with nine other leading and concerned physicians formed a working group devoted to creating a treatment protocol against COVID-19. The protocol they devised, called MATH+ is intended for use in the hospitalized patient, with an emphasis on early initiation — as soon as the patient develops a need for supplemental oxygen.

FLCCC's Mission
As a 501(c)(3) non-profit organization, FLCCC is dedicated to developing highly effective treatment protocols to prevent the transmission of COVID-19 and to improve the outcomes for patients ill with the disease. 
FLCCC's Team of Founders, Physicians, and Advisors
Founding Members /  MATH+ Developers
Paul E. Marik
M.D., FCCM, FCCP
Pierre Kory
M.D., M.P.A.
G. Umberto Meduri
M.D.
Founding Members
Keith Berkowitz
M.D., M.B.A.
Howard Kornfeld
M.D.
Fred Wagshul
M.D.
Joseph Varon
 M.D., FCCP, FCCM
.
Jose Iglesias
D.O.
.
Clinical Advisors
Scott Mitchell
MRCS
Eivind H. Vinjevoll
 M.D.

The FLCCC Alliance is currently in the process of building a network of physicians and other health professionals and health organizations who support their MATH+ Hospital Treatment Protocol for COVID-19, to help raise awareness and implementation of a treatment protocol that dramatically increases the life expectancy of critically ill COVID-19 patients.

In the hospitals that have adopted the protocol and initiated it early in the treatment of patients, both state and medical center data reporting the mortality of COVID-19 patients treated in these hospitals compares strongly with COVID-19 mortality rates published in studies from around the world. Although these data are in evolution, the MATH+ hospitals have been reporting hospital mortality between 4% and 10% (as of July 2020) while the hospital mortality from published reports in the US, Italy, and China average approximately 23%.

Dr. Pierre Kory testifies to Senate Committee about Ivermectin, Dec. 8, 2020
Informational Resources on FLCCC and Ivermectin
 
Articles 

Break Through Drug Ivermectin Shows “Astounding” Results Against Cornovirus

https://www.newsmax.com/us/ivermectin-drug-virus/2020/05/22/id/968688/

 

Doctors Cure 6,00 Patients with Covid-1p with Ivermectin

https://dominicantoday.com/dr/covid-19/2020/09/29/doctors-cure-6000-patients-with-covid-19-with-ivermectin/  

 

Physician Tells Senate, Ivermectin Is a COVID 'Wonder Drug'; If You Take It, You Will Not Get Sick'

https://www.cnsnews.com/article/national/susan-jones/physician-tells-senate-ivermectin-covid-wonder-drug-if-you-take-it-you
 

Dr. Pierre Kory Talks about Covid-19, Ivermectin, and FLCCC Alliance 
LCOALOGO_HOR WHT TEXT_RGB.png

CONDITIONS

Overview

COPD

Asthma

Chronic Bronchitis

Emphysema

Adult Onset Asthma

Chronic Infection

Sleep Study

Pre-Op Testing

Copyright © 2019, Lung Center of America dba Asthma & Respiratory Center of South Dayton Ohio

SM Icon-02.png
SM Icon-01.png
SM Icon-03-02.png